4.7 Article

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer

Related references

Note: Only part of the references are listed.
Article Cell Biology

Sialofucosylated podocalyxin is a functional E- and L-selectin ligand expressed by metastatic pancreatic cancer cells

Matthew R. Dallas et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2012)

Article Biochemistry & Molecular Biology

Methylation of an intronic region regulates miR-199a in testicular tumor malignancy

H-H Cheung et al.

ONCOGENE (2011)

Article Multidisciplinary Sciences

Urinary Podocyte-Associated mRNA profile in Various Stages of Diabetic Nephropathy

Min Zheng et al.

PLOS ONE (2011)

Article Biochemical Research Methods

High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer

Barbara Hjelm et al.

PROTEOMICS CLINICAL APPLICATIONS (2011)

Article Urology & Nephrology

Urine Podocyte mRNAs Mark Progression of Renal Disease

Yuji Sato et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)

Article Oncology

Expression of the cytoskeleton linker protein ezrin in human cancers

Benjamin Bruce et al.

CLINICAL & EXPERIMENTAL METASTASIS (2007)

Article Multidisciplinary Sciences

The CD34-Related Molecule Podocalyxin Is a Potent Inducer of Microvillus Formation

Julie S. Nielsen et al.

PLOS ONE (2007)

Article Biochemistry & Molecular Biology

Podocalyxin variants and risk of prostate cancer and tumor aggressiveness

G Casey et al.

HUMAN MOLECULAR GENETICS (2006)